BioNTech
BNTX
254 hedge funds and large institutions have $4.97B invested in BioNTech in 2025 Q3 according to their latest regulatory filings, with 34 funds opening new positions, 70 increasing their positions, 88 reducing their positions, and 36 closing their positions.
6% less first-time investments, than exits
New positions opened: 34 | Existing positions closed: 36
1.37% less ownership
Funds ownership: 22.37% → 21% (-1.4%)
2% less funds holding
Funds holding: 258 → 254 (-4)
13% less capital invested
Capital invested by funds: $5.72B → $4.97B (-$750M)
20% less repeat investments, than reductions
Existing positions increased: 70 | Existing positions reduced: 88
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
29% less call options, than puts
Call options by funds: $113M | Put options by funds: $159M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Dodge & Cox
San Francisco,
California
|
+$296M |
| 2 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
+$132M |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$47.5M |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$41.4M |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$37.3M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$289M |
| 2 |
P
Pfizer
New York
|
-$214M |
| 3 |
Invesco
Atlanta,
Georgia
|
-$64.9M |
| 4 |
BlackRock
New York
|
-$58.7M |
| 5 |
Bank of New York Mellon
New York
|
-$57.7M |
BNTX Hedge Fund Activity: Q3 2025 in Review
254 of the 7,620 institutional investors tracked by Wall St. Rank reported a position in BioNTech (BNTX) for Q3 2025, worth a combined $4.97B — down 13% from $5.72B a quarter earlier.
Sellers outnumbered buyers: 36 funds closed out of BNTX and 34 opened new positions — a net loss of 2 holders — while 88 trimmed existing stakes and 70 added.
The largest buyer was Dodge & Cox, adding an estimated $296M. The largest seller was Fidelity Investments, cutting an estimated $289M.
- 254 institutional investors held BioNTech (BNTX) as of Q3 2025, down from 258 in Q2 2025.
- Funds reported $4.97B of BioNTech stock for Q3 2025, down 13% quarter-over-quarter.
- 34 funds opened new BioNTech positions in Q3 2025 and 36 closed out, a net change of -2 holders.
- The largest BioNTech buyer in Q3 2025 was Dodge & Cox, an estimated $296M added.
- The largest BioNTech seller in Q3 2025 was Fidelity Investments, an estimated $289M sold.
Based on aggregated 13F filings for Q3 2025.